Rapt Therapeutics stock price target raised to $41 from $24 at Clear Street
PositiveFinancial Markets

Rapt Therapeutics has received a significant boost as Clear Street raised its stock price target from $24 to $41. This positive adjustment reflects growing confidence in the company's potential and could attract more investors, signaling a promising outlook for Rapt's future.
— Curated by the World Pulse Now AI Editorial System